A detailed history of Pinnacle Wealth Management Advisory Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pinnacle Wealth Management Advisory Group, LLC holds 3,792 shares of LLY stock, worth $3.41 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
3,792
Previous 3,745 1.26%
Holding current value
$3.41 Million
Previous $2.18 Million 35.14%
% of portfolio
0.32%
Previous 0.26%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $27,833 - $37,237
47 Added 1.26%
3,792 $2.95 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $2,625 - $3,095
5 Added 0.13%
3,745 $2.18 Million
Q3 2023

Oct 25, 2023

BUY
$434.7 - $599.3 $1,738 - $2,397
4 Added 0.11%
3,740 $2.01 Million
Q2 2023

Aug 02, 2023

BUY
$350.74 - $468.98 $83,476 - $111,617
238 Added 6.8%
3,736 $1.75 Million
Q1 2023

May 04, 2023

BUY
$310.63 - $364.82 $14,910 - $17,511
48 Added 1.39%
3,498 $1.2 Million
Q4 2022

Feb 06, 2023

BUY
$321.55 - $374.67 $17,363 - $20,232
54 Added 1.59%
3,450 $1.26 Million
Q3 2022

Nov 09, 2022

BUY
$296.48 - $337.87 $276,615 - $315,232
933 Added 37.88%
3,396 $1.1 Million
Q2 2022

Aug 01, 2022

BUY
$278.73 - $327.27 $251,971 - $295,852
904 Added 57.99%
2,463 $799,000
Q1 2022

May 05, 2022

SELL
$234.69 - $291.66 $40,601 - $50,457
-173 Reduced 9.99%
1,559 $446,000
Q4 2021

Jan 20, 2022

SELL
$224.85 - $279.04 $4,497 - $5,580
-20 Reduced 1.14%
1,732 $478,000
Q3 2021

Oct 29, 2021

BUY
$221.6 - $272.71 $7,091 - $8,726
32 Added 1.86%
1,752 $405,000
Q2 2021

Aug 10, 2021

SELL
$180.55 - $233.54 $9,027 - $11,677
-50 Reduced 2.82%
1,720 $395,000
Q4 2020

Feb 03, 2021

SELL
$130.46 - $172.63 $32,615 - $43,157
-250 Reduced 12.38%
1,770 $299,000
Q1 2020

May 08, 2020

SELL
$119.05 - $147.35 $9,166 - $11,345
-77 Reduced 3.67%
2,020 $280,000
Q3 2019

Nov 06, 2019

BUY
$106.79 - $116.16 $3,951 - $4,297
37 Added 1.8%
2,097 $235,000
Q1 2019

May 09, 2019

SELL
$111.31 - $131.02 $3,895 - $4,585
-35 Reduced 1.67%
2,060 $267,000
Q4 2018

Feb 05, 2019

SELL
$105.9 - $118.64 $19,062 - $21,355
-180 Reduced 7.91%
2,095 $242,000
Q3 2018

Nov 09, 2018

BUY
$85.86 - $107.31 $195,331 - $244,130
2,275 New
2,275 $244,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $853B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pinnacle Wealth Management Advisory Group, LLC Portfolio

Follow Pinnacle Wealth Management Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Management Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Management Advisory Group, LLC with notifications on news.